Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.11
- Piotroski Score 6.00
- Grade Buy
- Symbol (BIO)
- Company Bio-Rad Laboratories, Inc.
- Price $332.70
- Changes Percentage (2.19%)
- Change $7.12
- Day Low $323.23
- Day High $334.71
- Year High $387.99
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $482.50
- High Stock Price Target $565.00
- Low Stock Price Target $400.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$10.69
- Trailing P/E Ratio -26.85
- Forward P/E Ratio -26.85
- P/E Growth -26.85
- Net Income $-637,324,000
Income Statement
Quarterly
Annual
Latest News of BIO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Lawsuit alleging Target illegally collected biometric data can move forward, judge says
A federal judge denied Target's motion to dismiss a lawsuit alleging illegal collection of biometric data. The suit claims Target violated Illinois' BIPA by storing facial scans without consent. The j...
By USA Today | 22 hours ago -
Tech CEO Bryan Johnson reveals he eats his final meal of the day at 11 a.m. as part of his multimillion-dollar goal to reverse his biological age to 18
45-year-old CEO Bryan Johnson is on a mission to reverse his age by 27 years, aiming to achieve the health of an 18-year-old. His extreme regimen includes swapping blood with family members, strict di...
By Yahoo! Finance | 1 day ago -
Rand roadblock: Biotech bill's uncertain future
The BIOSECURE Act, with bipartisan support, aims to limit Chinese biotech companies in the U.S. Sen. Rand Paul's opposition complicates its progress, as supporters seek to attach it to the National De...
By POLITICO | 1 day ago
